BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20617373)

  • 1. Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells.
    Lee CC; Liu KJ; Wu YC; Lin SJ; Chang CC; Huang TS
    Inflammation; 2011 Jun; 34(3):209-21. PubMed ID: 20617373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats.
    Li Z; Li J; Zhu L; Zhang Y; Zhang J; Yao L; Liang D; Wang L
    Int J Nanomedicine; 2016; 11():6135-6148. PubMed ID: 27920521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sesamin inhibits lipopolysaccharide-induced proliferation and invasion through the p38-MAPK and NF-κB signaling pathways in prostate cancer cells.
    Xu P; Cai F; Liu X; Guo L
    Oncol Rep; 2015 Jun; 33(6):3117-23. PubMed ID: 25845399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+)-Episesamin exerts anti-neoplastic effects in human hepatocellular carcinoma cell lines via suppression of nuclear factor-kappa B and inhibition of MMP-9.
    Freise C; Trowitzsch-Kienast W; Ruehl M; Erben U; Seehofer D; Kim KY; Zeitz M; Somasundaram R
    Invest New Drugs; 2012 Dec; 30(6):2087-95. PubMed ID: 22048871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin.
    Kongtawelert P; Wudtiwai B; Shwe TH; Pothacharoen P; Phitak T
    Int Immunopharmacol; 2020 Sep; 86():106759. PubMed ID: 32663768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sesamin inhibits lipopolysaccharide-induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB.
    Jeng KC; Hou RC; Wang JC; Ping LI
    Immunol Lett; 2005 Feb; 97(1):101-6. PubMed ID: 15626481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products.
    Harikumar KB; Sung B; Tharakan ST; Pandey MK; Joy B; Guha S; Krishnan S; Aggarwal BB
    Mol Cancer Res; 2010 May; 8(5):751-61. PubMed ID: 20460401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Camptothecin suppresses expression of matrix metalloproteinase-9 and vascular endothelial growth factor in DU145 cells through PI3K/Akt-mediated inhibition of NF-κB activity and Nrf2-dependent induction of HO-1 expression.
    Jayasooriya RG; Park SR; Choi YH; Hyun JW; Chang WY; Kim GY
    Environ Toxicol Pharmacol; 2015 May; 39(3):1189-98. PubMed ID: 25941985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells.
    Wang KL; Hsia SM; Chan CJ; Chang FY; Huang CY; Bau DT; Wang PS
    Expert Opin Ther Targets; 2013 Apr; 17(4):337-49. PubMed ID: 23327692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sesamin inhibits lipopolysaccharide-induced inflammation and extracellular matrix catabolism in rat intervertebral disc.
    Li K; Li Y; Xu B; Mao L; Zhao J
    Connect Tissue Res; 2016 Sep; 57(5):347-59. PubMed ID: 27128308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
    Chia JS; Du JL; Hsu WB; Sun A; Chiang CP; Wang WB
    BMC Cancer; 2010 Apr; 10():175. PubMed ID: 20429953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sesamin inhibits hypoxia-stimulated angiogenesis
    Huang Y; Liu Z; Li L; Jiang M; Tang Y; Zhou L; Li J; Chen Y
    Food Funct; 2022 Aug; 13(17):8989-8997. PubMed ID: 35939045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic activity of sesamin through the activation of multiple signal pathways.
    Chung BH; Lee JJ; Kim JD; Jeoung D; Lee H; Choe J; Ha KS; Kwon YG; Kim YM
    Biochem Biophys Res Commun; 2010 Jan; 391(1):254-60. PubMed ID: 19917268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
    Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sesamin suppresses macrophage-derived chemokine expression in human monocytes via epigenetic regulation.
    Hsieh CC; Kuo CH; Kuo HF; Chen YS; Wang SL; Chao D; Lee MS; Hung CH
    Food Funct; 2014 Oct; 5(10):2494-500. PubMed ID: 25117529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
    Hwang YP; Yun HJ; Choi JH; Kang KW; Jeong HG
    Mol Nutr Food Res; 2010 Jul; 54(7):977-90. PubMed ID: 19943262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimetastatic Effects of Sesamin on Human Head and Neck Squamous Cell Carcinoma through Regulation of Matrix Metalloproteinase-2.
    Chen JM; Chen PY; Lin CC; Hsieh MC; Lin JT
    Molecules; 2020 May; 25(9):. PubMed ID: 32397656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells.
    Kim MH; Jeong YJ; Cho HJ; Hoe HS; Park KK; Park YY; Choi YH; Kim CH; Chang HW; Park YJ; Chung IK; Chang YC
    Oncol Rep; 2017 Feb; 37(2):777-784. PubMed ID: 27959445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.